In March 2025, the company announced new options for any direct-to-consumer giving of its Wegovy weight loss drug. The company proven a new pharmacy, referred to as NovoCare, which would cost clients $499 every month for entry to the drug, a lot less than 50 percent the price of the drug via other pharmaceutical distribution networks.[fifty three]R